{"id":"https://openalex.org/W4367304594","doi":"https://doi.org/10.1212/wnl.0000000000202566","title":"Glucosamine and Tau protein phosphorylation in a brain permanent-ischemia animal model: a paradoxical effect? (P3-5.006)","display_name":"Glucosamine and Tau protein phosphorylation in a brain permanent-ischemia animal model: a paradoxical effect? (P3-5.006)","publication_year":2023,"publication_date":"2023-04-25","ids":{"openalex":"https://openalex.org/W4367304594","doi":"https://doi.org/10.1212/wnl.0000000000202566"},"language":"en","primary_location":{"id":"doi:10.1212/wnl.0000000000202566","doi":"https://doi.org/10.1212/wnl.0000000000202566","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000202566","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5069299334","display_name":"Valentina Quintana-Pe\u00f1a","orcid":"https://orcid.org/0000-0001-7489-6354","observed_orcids":["https://orcid.org/0000-0001-7489-6354"]},"institutions":[{"id":"https://openalex.org/I4210098771","display_name":"Fundaci\u00f3n Valle del Lili","ror":"https://ror.org/00xdnjz02","country_code":"CO","type":"other","lineage":["https://openalex.org/I4210098771"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Valentina Quintana","raw_affiliation_strings":["Neurology, Fundaci\u00f3n Valle del Lili"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neurology, Fundaci\u00f3n Valle del Lili","institution_ids":["https://openalex.org/I4210098771"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Carlos Cardozo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I76842071","display_name":"Universidad Icesi","ror":"https://ror.org/02t54e151","country_code":"CO","type":"education","lineage":["https://openalex.org/I76842071"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Carlos Cardozo","raw_affiliation_strings":["Universidad Icesi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad Icesi","institution_ids":["https://openalex.org/I76842071"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112043225","display_name":"Cesar Augusto Arango","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098771","display_name":"Fundaci\u00f3n Valle del Lili","ror":"https://ror.org/00xdnjz02","country_code":"CO","type":"other","lineage":["https://openalex.org/I4210098771"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Cesar Arango","raw_affiliation_strings":["Fundaci\u00f3n Valle del Lili"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fundaci\u00f3n Valle del Lili","institution_ids":["https://openalex.org/I4210098771"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087367245","display_name":"Juliana Rengifo","orcid":"https://orcid.org/0000-0003-3870-8672","observed_orcids":["https://orcid.org/0000-0003-3870-8672"]},"institutions":[{"id":"https://openalex.org/I76842071","display_name":"Universidad Icesi","ror":"https://ror.org/02t54e151","country_code":"CO","type":"education","lineage":["https://openalex.org/I76842071"]}],"countries":["CO"],"is_corresponding":false,"raw_author_name":"Juliana Rengifo","raw_affiliation_strings":["Universidad Icesi"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universidad Icesi","institution_ids":["https://openalex.org/I76842071"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"100","issue":"17_supplement_2","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.7860999703407288,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","score":0.7860999703407288,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","score":0.09600000083446503,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13796","display_name":"Neuroprotection in Cerebral Ischemia","score":0.045899998396635056,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucosamine","display_name":"glucosamine","score":0.9990000128746033},{"id":"https://openalex.org/keywords/tau-phosphorylation","display_name":"tau phosphorylation","score":0.8169999718666077},{"id":"https://openalex.org/keywords/o-glcnacylation","display_name":"O-GlcNAcylation","score":0.9020000100135803},{"id":"https://openalex.org/keywords/permanent-cerebral-ischemia","display_name":"permanent cerebral ischemia","score":0.7630000114440918},{"id":"https://openalex.org/keywords/middle-cerebral-artery-occlusion","display_name":"middle cerebral artery occlusion","score":0.8500000238418579},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.6489999890327454},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.843999981880188},{"id":"https://openalex.org/keywords/hyperphosphorylated-tau","display_name":"hyperphosphorylated tau","score":0.8610000014305115},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.6620000004768372},{"id":"https://openalex.org/keywords/ischemia-reperfusion-injury","display_name":"ischemia-reperfusion injury","score":0.6480000019073486},{"id":"https://openalex.org/keywords/neuroinflammation","display_name":"neuroinflammation","score":0.5059999823570251},{"id":"https://openalex.org/keywords/cell-death","display_name":"cell death","score":0.35499998927116394},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.3160000145435333}],"concepts":[{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.6991807818412781},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6596925258636475},{"id":"https://openalex.org/C2778125326","wikidata":"https://www.wikidata.org/wiki/Q327506","display_name":"Glucosamine","level":2,"score":0.6367756128311157},{"id":"https://openalex.org/C2779581417","wikidata":"https://www.wikidata.org/wiki/Q1931577","display_name":"Thrombolysis","level":3,"score":0.5407575964927673},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5142988562583923},{"id":"https://openalex.org/C11960822","wikidata":"https://www.wikidata.org/wiki/Q242736","display_name":"Phosphorylation","level":2,"score":0.50166916847229},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4862293303012848},{"id":"https://openalex.org/C2778820722","wikidata":"https://www.wikidata.org/wiki/Q4862390","display_name":"Brain ischemia","level":3,"score":0.47950202226638794},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.4477522075176239},{"id":"https://openalex.org/C2778236600","wikidata":"https://www.wikidata.org/wiki/Q592324","display_name":"Immunofluorescence","level":3,"score":0.43461501598358154},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.34729257225990295},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34518957138061523},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.3031119704246521},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1449565291404724},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.1354665458202362},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.13319867849349976},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.0},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1212/wnl.0000000000202566","doi":"https://doi.org/10.1212/wnl.0000000000202566","is_oa":false,"landing_page_url":"https://doi.org/10.1212/wnl.0000000000202566","pdf_url":null,"source":{"id":"https://openalex.org/S79704628","display_name":"Neurology","issn_l":"0028-3878","issn":["0028-3878","1526-632X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Neurology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3137537896","https://openalex.org/W6981335159","https://openalex.org/W3149695244","https://openalex.org/W4393062239","https://openalex.org/W2392520733","https://openalex.org/W2024643386","https://openalex.org/W2082004863","https://openalex.org/W2538471458","https://openalex.org/W2383675160","https://openalex.org/W2389314332"],"abstract_inverted_index":{"Objective:":[0],"The":[1,53,159,210],"aim":[2],"is":[3,59,227],"to":[4,48,66,143,238,292,298,341],"establish":[5],"if":[6],"glucosamine":[7,111,200,218,265,276],"administration":[8],"reduces":[9],"the":[10,27,97,164,180,217,247,264,307,325],"levels":[11],"of":[12,19,36,55,96,109,112,212,250,309,327],"Tau":[13,57,242],"phosphorylation":[14,196],"in":[15,195,216,232,257,306,324],"an":[16,103],"animal":[17],"model":[18],"permanent":[20,172,235],"ischemia.":[21,120],"Background:":[22],"Thrombolysis":[23],"and":[24,75,135,154,255],"thrombectomy)":[25],"are":[26,38,46,285],"main":[28],"treatments":[29],"for":[30,41,311,316,329,335],"stroke.":[31],"However,":[32,234],"a":[33,184,314,332],"significant":[34,193],"number":[35,211],"patients":[37],"not":[39],"eligible":[40],"these":[42],"treatments.":[43],"Alternative":[44],"managements":[45],"necessary":[47],"reduce":[49],"post-stroke":[50],"consequences":[51],"(PSC).":[52],"aggregation":[54],"hyperphosphorylated":[56],"(P-Tau)":[58],"observed":[60,198],"after":[61,199,225],"brain":[62,125,230],"ischemia":[63,88,173,236],"which":[64,244],"leads":[65,237],"PSC.":[67],"Glucosamine":[68,252],"has":[69,290,296,302,320,339],"demonstrated":[70],"positive":[71,185],"effects":[72,77,249,279],"on":[73,331],"stroke":[74,226],"controversial":[76],"over":[78],"Tau.":[79],"Design/Methods:":[80],"Twelve":[81],"male":[82],"Wistar":[83],"rats":[84],"were":[85,127,157],"included.":[86],"Focal":[87],"(six":[89],"hours)":[90],"without":[91],"reperfusion":[92],"induced":[93],"by":[94,163,280],"occlusion":[95],"middle":[98],"cerebral":[99],"artery":[100],"(MCAO)":[101],"with":[102,131,187],"intraluminal":[104],"monofilament.":[105],"A":[106,192],"single":[107],"dose":[108],"intraperitoneal":[110],"200":[113],"mg/kg":[114],"was":[115,122,141,161,197,214],"administered":[116],"60":[117],"min":[118],"before":[119],"Control":[121],"saline.":[123],"Histological":[124],"sections":[126],"processed":[128],"using":[129],"immunofluorescence":[130,145],"primary":[132],"antibodies":[133],"(anti-O-GlcNAc":[134],"anti-pTau-ser":[136],"396).":[137],"Image":[138],"J":[139],"software":[140],"used":[142],"measure":[144],"signal":[146],"intensity.":[147],"Descriptive":[148],"statistics,":[149],"linear":[150],"regression,":[151],"Mann-Whitney":[152],"test,":[153],"Pearson":[155],"correlation":[156,186],"used.":[158],"study":[160,259],"authorized":[162],"ethics":[165],"committee.":[166],"Results:":[167],"P-Tau":[168,178,256],"raised":[169],"significantly":[170],"under":[171],"as":[174,176,313],"well":[175],"anti-O-GlcNAc.":[177],"at":[179],"serine":[181],"396":[182],"had":[183,267],"anti-O-GlcNAc":[188],"(0.33,":[189],"p:":[190,203,208],"<0001)":[191,204],"increase":[194],"(coef":[201],"9565":[202],"(17524":[205],"vs":[206,221],"13001":[207],"<0001).":[209],"cells":[213],"higher":[215],"group":[219,266],"(358":[220],"203).":[222],"Conclusions:":[223],"O-GlcNAcylation":[224,254],"protective":[228],"against":[229],"injury":[231],"reperfusion.":[233],"irreversible":[239],"changes":[240],"including":[241],"hyperphosphorylation":[243],"could":[245],"decrease":[246],"neuroprotective":[248,278],"O-GlcNAcylation.":[251],"increased":[253],"our":[258],"(a":[260],"paradoxical":[261],"reaction).":[262],"Nonetheless,":[263],"less":[268],"cell":[269],"destruction":[270],"what":[271],"it":[272],"may":[273],"implies":[274],"that":[275],"exerts":[277],"other":[281],"mechanisms.":[282],"Further":[283],"investigations":[284],"needed.":[286],"Disclosure:":[287],"Dr.":[288,300,318,337],"Quintana":[289],"nothing":[291,297,340],"disclose.":[293,299,342],"Mr.":[294],"Cardozo":[295],"Arango":[301,319],"received":[303,321],"personal":[304,322],"compensation":[305,323],"range":[308,326],"$500-$4,999":[310,328],"serving":[312,330],"Consultant":[315],"Procaps.":[317],"Speakers":[333],"Bureau":[334],"Lundbeck.":[336],"Rengifo":[338]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2023-04-29T00:00:00"}